Bearer of rare ‘One Ring’ card from ‘Lord of the Rings’ lore could fetch $2 million and experience hefty tax invoice

Bearer of rare ‘One Ring’ card from ‘Lord of the Rings’ lore could fetch  million and experience hefty tax invoice


Essential Points
  • An specific in Toronto reportedly uncovered a just one-of-a-type actively playing card as portion of a specific “Magic: The Collecting” edition in June.
  • Collectors have provided community bids of tens of millions of dollars for the “The One particular Ring” serialized card.
  • If offered, the “ring bearer” would probably pay a top rated tax charge of 53.53% on fifty percent of the profits from the transaction, experts said.
  • Based mostly on described bids, the full tax invoice could amount to up to roughly 780,000 Canadian dollars (about $588,000), in a person possible circumstance.



Supply

These underperforming groups may deliver AI-electric appeal. Here’s why.
Finance

These underperforming groups may deliver AI-electric appeal. Here’s why.

ETF Edge These underperforming groups may deliver AI-electric appeal. Here’s why. Published Sat, Nov 15 202511:00 AM EST Blair Bao WATCH LIVE Source

Read More
Warren Buffett’s Berkshire Hathaway reveals new position in Alphabet
Finance

Warren Buffett’s Berkshire Hathaway reveals new position in Alphabet

Warren Buffett speaks during the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska on May 3, 2025. CNBC Warren Buffett’s Berkshire Hathaway revealed a new position in Alphabet, making the Google parent the conglomerate’s 10th largest equity holding at the end of September, according to a regulatory filing. Berkshire disclosed a $4.3 billion stake in […]

Read More
Stocks making the biggest moves midday: Whirlpool, Topgolf Callaway, Nvidia, Stubhub & more
Finance

Stocks making the biggest moves midday: Whirlpool, Topgolf Callaway, Nvidia, Stubhub & more

Check out the companies making the biggest moves midday: Scholar Rock — The Cambridge, Massachusetts-based biotech jumped 23% after saying it ” completed constructive and collaborative in-person Type A meeting ” with the FDA on Wednesday for a biologics license application for apitegromab, a spinal muscular atrophy treatment. Officials from Novo Nordisk’s Catalent Indiana joined […]

Read More